V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200006245 | 200011533 | 1.49 | 126.3 | Palliative (P) | 2017-01-10 | 2017-01-24 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101782404 |
| 200006246 | 200011534 | null | 99 | null | 2018-04-14 | 2018-04-15 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100213999 |
| 200006247 | 200011535 | 0 | 0 | Palliative (P) | 2019-03-29 | 2019-04-26 | Ipilimumab | 02 | N | IPILIMUMAB | 100835646 |
| 200006250 | 200011538 | null | 56.4 | Palliative (P) | 2018-09-19 | 2018-09-20 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100403627 |
| 200006252 | 200011540 | 1.8 | 111 | Palliative (P) | 2020-04-28 | 2020-04-30 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100980801 |
| 200006253 | 200011541 | 1.71 | 71 | Palliative (P) | 2016-05-01 | 2016-05-17 | Dacarbazine | 02 | null | IPILIMUMAB | 100927027 |
| 200006254 | 200011542 | 1.7 | 84 | Adjuvant (A) | 2020-09-07 | 2020-09-19 | null | 02 | null | TRIAL UNSPECIFIED | 101098756 |
| 200006255 | 200011543 | 1.65 | 75.8 | Palliative (P) | 2016-12-15 | 2017-04-10 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101769760 |
| 200006257 | 200011545 | 1.83 | 87.8 | null | 2018-09-28 | 2018-09-29 | TRANSPLANT FLUDARABINE + TREOSULFAN | 01 | null | TRIAL UNSPECIFIED | 101852285 |
| 200006258 | 200011546 | null | 43.4 | Palliative (P) | 2018-02-14 | 2018-02-14 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101477715 |
| 200006260 | 200011548 | 1.9 | 72.7 | Palliative (P) | 2015-10-11 | 2016-03-21 | null | null | N | TRIAL | 100189175 |
| 200006261 | 200011549 | 1.65 | 59.4 | Palliative (P) | 2018-11-10 | 2018-11-17 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100667509 |
| 200006266 | 200011554 | 1.83 | 96.2 | Palliative (P) | 2016-04-22 | 2016-04-29 | DABRAFENIB | 02 | N | DABRAFENIB | 100652942 |
| 200006267 | 200011555 | 1.67 | 67 | Palliative (P) | 2016-11-05 | 2019-08-23 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101002006 |
| 200006268 | 200011556 | 1.7 | 120.2 | Palliative (P) | 2017-04-11 | 2017-04-16 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100779486 |
| 200006269 | 200011557 | 1.69 | 76.7 | Palliative (P) | 2019-03-28 | 2019-04-02 | null | 02 | null | TRIAL UNSPECIFIED | 100503779 |
| 200006271 | 200011559 | 0 | 0 | Palliative (P) | 2017-11-12 | 2017-12-06 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100804969 |
| 200006274 | 200011561 | 1.78 | 64.15 | Palliative (P) | 2017-10-06 | 2018-02-23 | Ipilimumab | null | N | IPILIMUMAB | 100584685 |
| 200006275 | 200011562 | null | 85 | null | 2016-10-14 | 2019-07-31 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101102053 |
| 200006276 | 200011563 | 1.76 | 113 | 03 | 2018-09-30 | 2018-10-04 | DABRAFENIB | N | N | IPILIMUMAB + NIVOLUMAB | 101770248 |
| 200006278 | 200011565 | 1.57 | 141.7 | 03 | 2017-06-11 | 2017-06-11 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101564127 |
| 200006281 | 200011568 | null | 93.9 | null | 2018-11-30 | 2018-11-30 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100894503 |
| 200006283 | 200011570 | 1.66 | 57.7 | Palliative (P) | 2020-12-01 | 2020-12-03 | Ipilimumab | 02 | N | IPILIMUMAB | 101855769 |
| 200006284 | 200011571 | 1.68 | 50.4 | Palliative (P) | null | 2019-06-07 | null | null | null | BINIMETINIB + ENCORAFENIB | 100935568 |
| 200006291 | 200011578 | 1.58 | 114 | Palliative (P) | 2019-02-20 | 2019-03-03 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100857513 |
| 200006294 | 200011581 | 1.89 | null | Palliative (P) | 2019-05-17 | 2019-05-17 | INTERIM Trial | 2 | null | IPILIMUMAB + NIVOLUMAB | 100777524 |
| 200006297 | 200011584 | 1.78 | 72.9 | null | 2020-06-29 | 2020-07-06 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101028212 |
| 200006304 | 200011591 | 1.79 | 59.65 | Palliative (P) | 2018-12-08 | 2019-01-05 | DABRAFENIB | 02 | null | DABRAFENIB | 100169903 |
| 200006306 | 200011593 | 1.73 | 78.4 | Palliative (P) | 2018-10-03 | 2018-10-07 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101145948 |
| 200006307 | 200011594 | 1.72 | 97 | Palliative (P) | 2017-02-19 | 2017-03-01 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101639873 |
| 200006309 | 200011596 | 0 | 0 | Adjuvant (A) | 2017-03-23 | 2017-11-12 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101089731 |
| 200006311 | 200011598 | 1.81 | 53.5 | Palliative (P) | 2019-05-23 | 2019-06-10 | TALIMOGENE LAHERPAREPVEC | N | N | IPILIMUMAB + NIVOLUMAB | 100333840 |
| 200006313 | 200011600 | 1.78 | 92.8 | Palliative (P) | 2017-12-23 | 2018-03-25 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101036125 |
| 200006315 | 200011602 | null | 80 | Palliative (P) | 2019-06-05 | 2019-07-24 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100046365 |
| 200006319 | 200011605 | null | 77 | Palliative (P) | 2018-11-05 | 2018-11-14 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100021003 |
| 200006320 | 200011606 | 1.65 | 100 | Palliative (P) | 2017-05-17 | 2017-05-17 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100423081 |
| 200006321 | 200011607 | null | 103.2 | Palliative (P) | 2018-09-26 | 2018-09-27 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101239827 |
| 200006323 | 200011609 | 1.63 | 89.3 | Palliative (P) | 2017-12-14 | 2017-12-15 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101555830 |
| 200006326 | 200011612 | 1.63 | 74 | Palliative (P) | 2021-09-20 | 2021-10-24 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101796085 |
| 200006329 | 200011615 | 1.72 | 78 | Palliative (P) | 2019-07-19 | 2019-07-25 | IPILIMUMAB + NIVOLUMAB | 01 | null | TRIAL UNSPECIFIED | 101808118 |
| 200006330 | 200011616 | 1.76 | 75.2 | 03 | 2018-09-08 | 2018-09-16 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100931156 |
| 200006332 | 200011618 | 1.81 | 78.4 | Palliative (P) | 2016-12-11 | 2016-12-24 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101009505 |
| 200006337 | 200011622 | null | 80.2 | Palliative (P) | 2017-05-18 | 2017-05-29 | null | 02 | N | IPILIMUMAB | 101377656 |
| 200006338 | 200011623 | null | null | Palliative (P) | 2016-10-03 | 2016-11-04 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100810821 |
| 200006340 | 200011625 | 1.79 | 109.2 | Palliative (P) | 2018-07-06 | 2018-12-01 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101092561 |
| 200006342 | 200011627 | 1.83 | 103.2 | Palliative (P) | 2022-02-06 | 2022-02-21 | null | 01 | null | TRIAL UNSPECIFIED | 101467891 |
| 200006343 | 200011628 | 1.79 | 104 | Adjuvant (A) | 2019-05-05 | 2019-06-22 | DABRAFENIB | 02 | N | DABRAFENIB | 100049485 |
| 200006344 | 200011629 | 1.62 | 82.3 | null | null | 2016-03-25 | null | N | null | IPILIMUMAB + NIVOLUMAB | 101402562 |
| 200006345 | 200011630 | 1.77 | 63.5 | Palliative (P) | 2017-05-05 | 2018-06-06 | TALIMOGENE LAHERPAREPVEC | 02 | null | IPILIMUMAB + NIVOLUMAB | 101734354 |
| 200006346 | 200011631 | 1.61 | 77.5 | Palliative (P) | 2019-06-06 | 2019-06-20 | IPILIMUMAB + NIVOLUMAB | 02 | N | TRIAL UNSPECIFIED | 101185765 |